The U.S. Food and Drug Administration has approved the antibiotic meropenem for treating children less than 3 months old for abdominal infections, according to the National Institutes of Health.
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO), has granted a favourable recommendation for marketing permission of Wockhardt's novel antibiotic, Zaynich ...
Purpose. The chemistry, pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, efficacy and safety in humans, and formulary considerations of doripenem are reviewed. Summary.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results